Entities / Person
Jean-Paul Kress.
Person
- Reports this week
- 0
- Active events
- 0
- Connections
- 2
What's happening
Gone quiet
No new reports in 90+ days-
VOR licensed telitacicept from RemeGen and appointed Jean-Paul Kress as CEO and Chairman of the company.Speculative1 report
-
VOR granted stock options to Jean-Paul Kress for commencing employment on July 2, 2025.Speculative1 report
-
Jean-Paul Kress was appointed CEO and Chairman of the Board of VOR.Some support5 reports
No events began in the chosen period. Widen it, or reset.
Connections
The 1 strongest of 2, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
VOR Structural
VOR employs Jean-Paul Kress as CEO and Chairman of the Board.